Henderson Jane sold APGE
February 2, 2026 · Form 4 insider transaction
Henderson Jane sold 100 shares of Apogee Therapeutics, Inc. at $66.89 per share, a transaction worth $6.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$66.89
Total value
$6.7K
InsiderHenderson Jane
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2026
Filing dateFebruary 4, 2026
Shares owned after183,371
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.